Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

• Lara Rodríguez-Sánchez,
• Mark Emberton,
• Theo de Reijke,
• Phillip Stricker,
• Bernardino Miñana,
• Fernando Bianco,
• Jose Luis Dominguez Escrig,
• Anna Lantz,
• Rafael Sanchez-Salas

Affiliations

Lara Rodríguez-Sánchez

ORCiD

Urology Department, Institut Mutualiste Montsouris, Paris, France

Mark Emberton

ORCiD

Division of Surgery and Interventional Science, University College London, London, UK

Theo de Reijke

ORCiD

Department of Urology, UMC Amsterdam University Hospital, Amsterdam, the Netherlands

Phillip Stricker

ORCiD

Department of Urology, St. Vincent’s Private Hospital and Clinic, Melbourne, Australia

Bernardino Miñana

ORCiD

Department of Urology, Clinica Universidad de Navarra, Madrid, Spain

Fernando Bianco

ORCiD

Urological Research Network, Nova Southeastern University, Hollywood, FL, USA

Jose Luis Dominguez Escrig

ORCiD

Department of Urology, Instituto Valenciano de Oncologia, Valencia, Spain

Anna Lantz

ORCiD

Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden

Rafael Sanchez-Salas

ORCiD

Department of Surgery, Division of Urology, McGill University, Montreal, QC, Canada